FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) submitted by Mainpointe Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Common Cold

Drugs mentioned

• TUXARIN (Codeine phosphate and chlorpheniramine maleate)

Snippet

SUPPL AP for TUXARIN (CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE)